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Abstract 
Background: Gestational trophoblastic disease (GTD) comprises a spectrum of interrelated tumours 
including complete and partial hydatidiform mole, placental site trophoblastic tumours and 
choriocarcinoma.
Objective: To evaluate the clinical presentation, management and treatment outcomes of gestational 
trophoblastic diseases in a tertiary health institution. 
Methodology: This was a descriptive study of all cases of gestational trophoblastic diseases managed at 
Ebonyi State University Teaching Hospital, Abakaliki over a five-year period.  
Results: The incidence of GTD was 3.58 per 1000 deliveries. The age range was 19-55 years and the mean 
age was 33.4±7.4 years. The mean gravidity was 6 and women who are gravida 5 and above accounted 
for 63.3% of those that presented with GTD. Gestational trophoblastic disease was commonly found in 
women with blood group O (60%) and 46.7% of cases of gestational trophoblastic disease occured in age 
group 30-39 while 23.3% of gestational trophoblastic diseases occured in women 40 years and above. 
The commonest clinical presentation was recurrent vaginal bleeding 96.7%. Suction curettage (66.7%) 
was the commonest form of treatment offered to those with GTD in EBSUTH. Total Abdominal 
hysterectomy and chemotherapy was performed only in 10% of the patients. The commonest 
complication was haemorrhage (40%). Maternal death attributable to GTD was 10%. About 60% of the 
patients did not turn up for follow up.
Conclusion: Early presentation and proper treatment of this condition is emphasized. There is need for 
adequate follow-up of these patients. 
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Introduction
Gestational trophoblastic disease (GTD) Focal swell ing of vi l lous tissue, focal 
comprises a spectrum of interrelated tumours, trophoblastic hyperplasia and embryonic or fetal 
5, 6
tissue affecting only the syncytiotrophoblast . including complete and partial hydatidiform 
In the majority of complete moles, all of the mole, placental site trophoblastic tumours 
1(PSTT) and choriocarcinoma . Hydatidiform mole genetic material is male in origin and results from 
is the benign form of trophoblastic disease, the fertilization of an empty oocyte lacking 
which as a potentially malignant condition may maternal DNA. The chromosome count in 
progress to the frankly malignant disorders of complete mole is most commonly 46XX and few 
2
choriocarcinoma . Despite the rarity of GTD, have 46XY karyotype which results from one 
patients generally have very successful sperm that duplicates its DNA, or less frequently 
7outcomes with overall cure rates in excess of from dispermy .
3
95% . 
 Partial hydatidiform mole is often associated 
Complete or classical hydatidiform mole is with one haploid maternal and two haploid 
described as a generalized swelling of the villous 
tissue, diffuse trophoblastic hyperplasia with 
4variable degrees of cellular atypia , with no 
embryonic or fetal tissue affecting both the 
syncytiotrophoblast and cytotrophoblast while 
partial hydatidiform mole is characterized by 
paternal sets of chromosomes as a result of and high parity groups. This study therefore, 
dispermic fertilization of a haploid ovum, or a aims to describe the epidemiology of gestational 
fertilization of haploid ovum with diploid trophoblastic disease among gynaecological 
6
spermatozoa . Partial mole is usually a triploid admissions in EBSUTH which is hoped to reflect 
7 the prevalence of the disease in this part of containing 69XXX or 69XXY Chromosome . 
Nigeria.
Worldwide, there is marked temporal, regional 
Methodologyand ethnic variations in the incidence of 
4, 8 Study Backgroundhydatidiform mole . High incidence of molar 
Ebonyi State University Teaching Hospital, pregnancy is reported in China, Malaysia, 
Abakaliki (EBSUTH) is one of the two tertiary Singapore, Hong Kong, Indonesia, Philippines, 
health facilities in Ebonyi State located at South East Asia, Northern Europe, Middle East, 
1 Abakaliki, the state capital and receives referrals Eastern and Central Africa .  The often cited 
from all parts of the state and the neighbouring worldwide incidence is between 0.5-2.5 per 
9 states of Benue, Enugu, Cross-River and Abia. 1000 deliveries .  The frequency of molar 
Consultants' gynaecologists with resident pregnancy in western countries is about 1in 
10 doctors run the gynaecological clinics every day 1000-1200 pregnancies . In Nigeria, the 
of the week. Diagnosis of gestational incidence among Igbo women is 0.82 per 1000 
11 trophoblastic diseases was made mainly on deliveries and generally ranges between 0.8 
12 cl inical  history,  physical  examination,  and 4.88 per 1000 deliveries in Nigeria . The 
u l t ra s o n o g ra p h y,  s e r u m  â  h C G  a n d  estimated incidence of complete mole is 1 per 
histopathological examination of  obtained 1000-2000 pregnancies whereas the incidence 
5 specimen where possible. All cases of diagnosed of partial mole is around 1 per 700 pregnancies  
gestational trophoblastic disease are admitted globally. 
and managed in the gynaecological ward of 
EBSUTH' Their management is individualized The incidence of gestational trophoblastic 
depending on the clinical stage of the disease disesae is higher in women younger than 20 
and the assessed risk level.years and older than 40 years of age, nulliparous 
women,  patients of low socio- economic status, 
Study Designand in women whose diets are deficient in 
13 This was a retrospective study of all cases of protein, folic acid, and carotene . The most 
gestational trophoblastic disease admitted and remarkable findings are that blood group A 
managed in the gynaecological ward of EBSUTH women impregnated by group O men have an 
over a 5 year period (January 1, 2003 to almost 10-fold greater risk of developing 
December 31, 2007).  There were a total of 8,383 choriocarcinoma than group A women 
deliveries and 1,352 gynaecological admissions impregnated by group A partners. Furthermore, 
in the period under review. After obtaining women with blood group AB tend to have a 
13 permission from the Ethical Research Committee  relatively worse prognosis . There is an 
of the hospital, the case notes of all gestational increased risk of GTD in a woman with 
trophoblastic disease were retrieved from the spontaneous abortion, the risk being three times 
14 medical records department and relevant data higher after two spontaneous abortions .  
were extracted. Information collected are 
related to socio-biological variables( age, parity, The greater proportion of Ebonyi State is made of 
gravidity, educational level, blood group and the low socio-economic group with tendency 
history of antecedent pregnancy) uterine size at towards high parity which favours the 
p r e s e n t a t i o n ,  c l i n i c a l  p r e s e n t a t i o n ,  occurrence of gestational trophoblastic disease. 
investigations and treatment options employed, Moreover, the epidemiology of gestational 
outcome of the treatment options were trophoblastic disease among gynaecological 
obtained and analyzed using Epi Info (2005) 3.3.2 admissions has not been studied and 
version.documented in EBSUTH which serves as one of 
the major referral centres for these low income 
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From January 1, 2003 to December 31, 2007 a In this study, 15 patients (50%) had abortion in 
total of 8383 deliveries were conducted at the antecedent pregnancy while 12 patients 
Ebonyi State University teaching hospital, (40%) had live birth in the antecedent pregnancy. 
Abakaliki and a total of 30 cases of gestational Considering the educational status of the 
trophoblastic disease were treated and patients, 19 patients (63.3%) of women that 
histologically confirmed in the period under presented with GTD had no formal education. 
review giving a prevalence of 3.58 per 1000 Eighteen   patients (60%) were of blood group O. 
deliveries. A total of 1352 gynaecological cases Women with blood group A and blood group B 
were admitted into the gynaecological ward and accounted for 13.3% and 26.7% of cases of GTD 
GTD accounted for 2.2% of all gynaecological treated in EBSUTH respectively. Table 3 shows 
admissions in EBSUTH in the period under the clinical features of GTD in patients that 
review. The mean age of women that presented presented at the centre. Twenty nine patients 
with GTD in EBSUTH was 33.4 years ± 7.4 (2SD) (96.7%) presented with vaginal bleeding while 11 
and the age range was 19-55 years. The mean patients (36.7%) presented in the hospital with 
gravidity was 6. passage of vesicles. Fundal height was greater 
than gestational age in 17 patients (56.7%). The 
Table 1 shows the trend of GTD by year from presence of theca lutein cyst was found in 26.7% 
2003 to 2007 in EBSUTH. The year 2007 had the of the cases that were treated while 
highest prevalence of 8.3 per 1000 deliveries ultrasonography aided in the diagnosis of GTD in 
followed by 2006 with a prevalence of 4.5 per 73.3% (95% CI 54.1-87.7) of all the cases seen. 
1000 deliveries. Table 2 shows the socio- Pre-eclampsia and hyperemesis gravidarum 
demographic characteristics and reproductive complicated 16.7% and 13.3% of all the cases of 
history of patients with gestational trophoblastic GTD managed in EBSUTH respectively during the 
disease from 2003 to 2007. One patient (3.3%) study period.
was below 20 years and eight patients (26.7%) 
were in the age bracket of 20-29 years, while 14 Table 4 shows the various management options 
patients (46.7%) were between 30-39 years. employed in the treatment of gestational 
Seven patients (23.3%) were 40 years and above. trophoblastic disease from 2003-2007.  Twenty 
Seventy-percent of the patients that presented patients (66.7%) had suction curettage alone 
with GTD in EBSUTH were above 30 years. with no further treatment while four patients 
Nulliparas accounted for 10% of the women that (13.3%) had both suction curettage and 
presented with GTD while grandmultiparous chemotherapy. Chemotherapy alone was the 
women were 46.7%. Para 1-4 women accounted method of choice in three patients (10%) while 
for 43.3% of women with GTD in EBSUTH. t o t a l  a b d o m i n a l  h y s t e r e c t o m y  a n d  
chemotherapy was the treatment of choice in respectively. This study shows that hydatidiform 
10% of the patients. Table 5 shows the mole accounted for 80% of GTD seen in EBSUTH 
complications associated with GTD. Twelve with complete mole accounting for 60 % while 
patients (40%) had severe haemorrhage defined partial mole was seen in 20% of the cases. Six 
as blood loss above 1000ml in this study. Twenty patients (20%) were histologically confirmed to 
percent of the patients that presented with GTD have choriocarcinoma.
had choriocarcinoma while 6.7% of the cases of 
GTD seen were complicated by sepsis. Three Table 6 shows that 60% of the patients did not 
patients (10%) died from complications of GTD. come back for any sort of follow-up after their 
From this study, sixty three point three percent discharge from the hospital, while only a patient 
(63.3%) of women that presented with GTD were (3.3%) was followed up for over a year.
gravida 5 and above while gravida 2-4 and Discussion
primigravidas accounted for 30% and 6.7% of all Gestational trophoblastic disease refers to a 
the cases of GTD seen in EBSUTH in this study spectrum of proliferative disorders of the 
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22 23
placental trophoblast, with a wide range of of Lagos  and Ibadan .
15histologic appearances and clinical behaviours .
The incidence of gestational trophoblastic The differences in the incidence of gestational 
disease recorded in this study was 3.58 per 1000 trophoblastic disease reported in this study 
deliveries, which is higher than the often cited compared to similar studies done elsewhere 
world wide incidence of 0.5 to 2.5 per 1000 could be explained by the significant variations in 
2 geographic spread of the disease as well as deliveries  and also higher than 0.82 per 1000 
factors of race, socio-economic status, deliveries reported by Egwuatu and colleagues in 
nutritional variations among people studied and women from the same geopolitical zone as ours 
1,24-2711 the concept of variable host resistance . . However, the incidence of gestational 
Maternal age is the most consistent risk factor trophoblastic disease reported in Nigeria 0.87-
12 for gestational trophoblastic disease in every 4.88 per 1000 deliveries  is comparable with the 
region and ethnic group in which it has been findings in this study.
studied with most studies showing a significant 
incidence in risk in women delivering above age The incidence of hydatidiform mole in this study 
35 years and a further 10 fold increase beyond was 2.86 per 1000 or 1 in 349 deliveries which is 
28age 40 years . In this study, 14 patients (46.7%) comparable with 2.4 per thousand (or 1 in 416) 
16 were between ages 30-39 years while 23.3% deliveries recorded by Eniola and colleagues  in 
were 40 years and above. Ife and the  1 in 332 deliveries reported by 
17Obiechina and colleagues  in women at Onitsha , 
Increasing parity and gravidity were confirmed in Nigeria but higher than 1 in 676 deliveries 
18 this study as risk factors for the development of reported for Saudi Arabia . The incidence of 
gestational trophoblastic disease. Majority of complete hydatidiform mole in this study was 
the cases (90%) in this study occurred in parous 2.15 per 1000 deliveries lower than 3.42 per 
19 women. However, it is difficult to separate the 1000 deliveries reported by Dan in Uganda , 
influence of gravidity/parity from that of age on while that of partial hydatidiform mole was 0.72 
gestational trophoblastic disease. These findings per 1000 deliveries. The incidence of 
1,29
were consistent with other studies . Vaginal Choriocarcinoma of 0.72 per 1000 deliveries, 
bleeding of varying severity is the commonest found in this review compares favourably with 
4, 8
feature of gestational trophoblastic disease . In the  0.5 per 1000 deliveries reported by Moodley 
20 this study, 96.7% of the patients that presented and colleagues in South Africa  and earlier 
with gestational trophoblastic disease in EBSUTH studies in Ogbomoso, Nigeria (0.99 per 1000 
21 had vaginal bleeding. This is consistent with 80% deliveries)  but lower than those reported from 
24,25,30to 98.63% reported in other studies . patients with GTD actually confirmed passage of 
Abdominal pain, vomiting, increased blood vesicles. One of the striking features of GTD is 
pressure and anaemia were other important that of the uterus being too large for the period 
presenting symptoms, thus showing the of amenorrhoea. This sign is present in only 50% 
importance of these symptoms in the diagnosis of cases; sometimes the uterus is smaller than 
1normal, especially if the mole dies . In this study of hydatidiform mole. These clinical signs and 
the uterine size was larger than the gestational symptoms are particularly relevant for those 
age in 56.7% of women that had GTD.  It is patients presenting late.Theca lutein cysts, 
equally of interest to note that an excess of blood which are due to stimulation of the ovaries by 
group A or AB has been reported in a series of high level of hCG is one of the clinical features of 
321
219 diseases in Malaysia . There is some gestational trophoblastic disease . In this study, 
evidence that serologic incompatibilities eight patients (26.7%) were found to have theca 
between husbands and wives may be important. lutein cysts and three patients had bilateral theca 
Studies have shown excess risks for group A lutein cyst. This was comparable with 32.7% 
33reported by Dan in a hospital based study in women with group O husbands  as well as for 
19 34Uganda . group O women with group A husbands . In this 
study, 60% of patients with GTD were blood 
 Ultrasonography is the diagnostic method of group O. This was confirmed by Abdellatif and 
choice in some centres because of its reliability, colleagues who reported an incidence of 62% of 
 1
women with GTD having blood group O. Similar s e n s i t i v i t y  a n d  s a f e t y .  H o w e v e r,  
findings have been reported by other histopathological examination of products of 
35conception remains the current gold standard researchers .
31
for the identification of GTD . Ultrasonography 
contributed in the diagnosis of gestational 
trophoblastic disease in 88.5 to 95% of the cases 
24, 25
of GTD in other studies . In this study of gestational trophoblastic disease in some 
14populations . Studies from Italy and United ultrasonography contributed in the diagnosis of 
States suggest that the risk for complete molar GTD in 73.3% of women that presented with GTD 
pregnancy progressively increased with in EBSUTH.  The serum level of â-hCG is markedly 
decreasing levels of consumption of dietary elevated in GTD and when combined with urine 
36  hCG both in neat and dilute has proved useful in carotene and animal fat . In studies in 
the diagnosis and follow up of GTD. However, developing countries, cases were found in 
hCG estimations cannot be dependent upon association with lower socio-economic status. 
alone for absolute diagnosis of GTD, although This was consistent with the findings in this study 
1
in which 60% of those affected are peasant they usually add strong supporting evidence . In 
farmers and 63.3% of women afflicted with GTD this study, serum hCG was found to be elevated 
had no formal education. Education has been in all the patients that presented with GTD and 
used as a good proxy for the estimation of socio-about 10% of the patients had serum hCG 
37greater than 100,000 miu/ml. economic status in any given population . 
Anaemia, consequent upon prolonged vaginal 
The passage of vesicles in the uterine discharge is bleeding was very high in this review. Severe 
conclusive evidence but rarely occurs until anaemia (PCV< 18%) was found in 53.3% of 
1
women with GTD and was indirectly linked with abortion is eminent . In this study 36.7% of 
Socio-economic and nutritional factors have 
been cited as contributing to the high incidence 
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who have completed their families . In this study, all the maternal deaths of 10% recorded in this 
66.7% of patients treated for GTD had suction review. The unusually high maternal mortality 
curettage while 13.3% had both suction and morbidity in this study was due to late 
curettage and chemotherapy for patient with presentation of the patients in moribund 
high risk diseases and 10% of the patients had condition.
t o t a l  a b d o m i n a l  h y s t e r e c t o m y  a n d  
chemotherapy. Ten percent of the patients Complete hydatiform mole and partial 
treated for GTD had chemotherapy alone. The hydatidiform mole is both potentially malignant 
10. However, complete hydatidiform mole has factors considered for instituting chemotherapy 
higher degree of propensity to become are: high levels of hCG of more than four weeks 
malignant compared to partial mole. The risk of post evacuation (serum> 20,000 IU/L; urine > 
gestational trophoblastic neoplasia from partial 30,000 IU/24 hours), persistent uterine 
hydatidiform mole is less than 5-10% and that of haemorrhage, progressively rising serum beta 
10complete mole is 20% . All the choriocarcinoma hCG level at any time post evacuation, any 
found in this study occurred denovo after a live detectable hCG not showing tendency to 
birth and one, following an ectopic pregnancy. extinction four to six months post evacuation, 
Transformation from complete mole or partial evidence of brain, renal, hepatic, gastrointestinal 
mole to choriocarcinoma and a repeat tract or pulmonary metastases with any level of 
10
hydatidiform mole were not observed in this hCG . The use of prophylactic chemotherapy in 
study apparently because 60% of patients some of the patients was necessary because 
treated for GTD in this study did not have any majority of the patients with high risk disease do 
form of follow-up and only a patient  had follow- not turn up for or are lost to follow up. 
up for more than one year despite the presence 
of  high risk factors for malignant transformation This study shows that gestational trophoblastic 
such as pre-evacuation uterine size larger for disease is still a cause of significant morbidity and 
gestational period, age more than 40 years, mortality in our environment as opposed to what 
bilateral theca lutein cyst of more than 6cm size obtains in developed countries where early 
and pre-evacuation hCG level more than 100,000 diagnosis of the disease by ultrasonography and 
38miu/ml  which were present in some of the subsequent treatment before major bleeding 
patients in this study. episodes occur  is the norm. The need for early 
 presentation in the hospital and diagnosis of the 
The method of choice for the treatment of disease with subsequent initiation of the correct 
24 treatment to reduce morbidity and mortality hydatidiform mole is suction curettage . 
associated with this disease cannot be over However, certain authors have reported 
emphasized.  The fact that more than 60% of the decreased risk for the development of persistent 
patients with GTD refused to turn up for follow trophoblastic disease 10-15% when suction 
up despite adequate counselling strongly curettage is fol lowed by prophylactic 
2 4 , 2 5 emphasizes the need for the establishment of chemotherapy in high risk patients . 
GTD referral centres and effective follow-up Hysterectomy may also be performed with the 
facilities.mole in situ for women aged 40 years and over 
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